Controversy Surrounds Gender Dysphoria Treatments for Minors

Efforts to manage gender dysphoria in children should prioritize mental health counseling and compassionate care, according to Assistant Secretary of Health and Human Services Adm. Brian Christine. He emphasized that using hormone blockers and surgeries can have irreversible consequences for minors.

Adm. Christine, who manages public health programs within the Health and Human Services Department, supported a recent rule announced by the Trump administration. This rule prevents the use of Medicaid and the Children’s Health Insurance Program (CHIP) funds for puberty blockers, hormone therapy, and surgeries aimed at treating gender dysphoria in minors.

“Gender dysphoria is a real condition,” Christine told Fox News Digital. He noted that historically, few children were diagnosed, but recently there has been a significant rise in cases, which he views as a social phenomenon rather than a medical one.

According to Christine, most minors diagnosed with gender dysphoria overcome it with professional and compassionate counseling.

Admiral Brian Christine supports the Trump administration’s steps to block Medicaid and CHIP funding for gender transition treatments for minors.

The new rule specifies that Medicaid and CHIP will cease financial support for these procedures in children, although it does not prohibit them outright. This, according to Centers for Medicare and Medicaid Services (CMS) Administrator Dr. Mehmet Oz, aligns with scientific research, saves taxpayer funds, and shields minors from irreversible harm.

President Donald Trump voiced strong opposition to gender transition surgeries and hormone therapies in minors, labeling them as “barbaric.” He stated that such procedures inflict permanent damage on the young.

Christine differentiates between what he describes as “corrective care” and the term “gender-affirming care” used by its advocates. He argues that procedures like surgeries and hormone treatments harm rather than affirm.

Currently, 27 states have implemented restrictions on gender-affirming care for minors, according to health policy group KFF. The new regulation, effective Oct. 13, provides for a six-month transition period for children already receiving hormone treatments to taper off the medications.

Christine remarked that historically, gender dysphoria primarily affected a small percentage of adult males. The recent surge in cases among minors, especially young females, suggests an ideological shift rather than a purely medical issue, he said.

Christine is critical of the growing societal acceptance of gender fluidity, suggesting it misrepresents biological sex differences.